Literature DB >> 14602312

Pulmonary resection following lung transplantation.

Torin P Fitton1, Brian T Bethea, Marvin C Borja, David D Yuh, Stephen C Yang, Jonathan B Orens, John V Conte.   

Abstract

BACKGROUND: The morbidity of lung transplantation is higher than other solid organ transplants. Little is known about the outcomes of patients who require pulmonary resection following lung transplantation. We reviewed our experience to evaluate and discern any variables affecting outcome of pulmonary resections performed following lung transplantation.
METHODS: A retrospective review of the lung transplant database was performed. Data are presented as mean +/- standard error (median).
RESULTS: A total of 136 lung transplants (80 single lung transplants [SLT], 55 bilateral lung transplants [BLT], and 3 heart-lung transplants [HLT]) were performed from August 1995 to February 2002. Twelve pulmonary resections, 7 lobectomies, and 5 wedge resections were performed on 11 patients. The indication for lobectomy was infection in 5 of 7 lobectomies (3 fungal, 2 bacterial), mass in 1 of 7, and infarction in 1 of 7. The indication for wedge resection was native lung hyperinflation in 4 of 5 wedge resections and mass in 1 of 5. The native lung was resected in 3 of 7 lobectomies and 4 of 5 wedge resections. An allograft lobectomy was performed following 1 SLT and 3 BLT and a wedge resection was performed after 1 SLT. The mean time to pulmonary resection was 12.4 +/- 3.9 (9.1) months. Survival postresection was 17.2 +/- 5.8 (8.3) months and 5 of 11 patients are still alive. There were no bronchial stump leaks following lobectomy.
CONCLUSIONS: Major pulmonary resections can safely be performed following lung transplant. We recommend early intervention to optimize outcomes.

Entities:  

Mesh:

Year:  2003        PMID: 14602312     DOI: 10.1016/s0003-4975(03)00975-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  Lung volume reduction followed by lung transplantation-considerations on selection criteria and outcome.

Authors:  Alexis Slama; Christian Taube; Markus Kamler; Clemens Aigner
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  Aspergillus fumigatus fungus ball in the native lung after single lung transplantation.

Authors:  Fernando Ferreira Gazzoni; Bruno Hochhegger; Luiz Carlos Severo; José Jesus Camargo
Journal:  J Bras Pneumol       Date:  2013 May-Jun       Impact factor: 2.624

3.  Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant.

Authors:  Assaf Moore; Mordechai R Kramer; Dror Rosengarten; Osnat Shtraichman; Alona Zer; Elizabeth Dudnik; Yasmin Korzets; Aaron M Allen
Journal:  Radiol Oncol       Date:  2020-04-17       Impact factor: 2.991

Review 4.  Postoperative Management of Hyperinflated Native Lung in Single-Lung Transplant Recipients with Chronic Obstructive Pulmonary Disease: A Review Article.

Authors:  Islam M Shehata; Amir Elhassan; Ivan Urits; Omar Viswanath; Leonardo Seoane; Courtney Shappley; Alan D Kaye
Journal:  Pulm Ther       Date:  2020-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.